by James Lyons-Weiler, PhD, Popular Rationalism, ©2026

(Apr. 6, 2026) — American medicine has been industrialized — standardized, franchised, and value-engineered in ways that maximize throughput and revenue while systematically reducing the quality of care delivered to individual patients. This is not primarily the product of malicious actors. It is the emergent property of incentive structures that reward volume over precision, protocol over judgment, and population averages over individual biology. The solution is not nostalgia. It is a funded, rigorous, reform-minded research agenda at NIH that asks which treatments work best for which patients — and is honest about what the evidence actually shows.

There is a moment, familiar to anyone who has eaten a fast food burger in the last decade, when you realize the patty is thinner than you remember, the bun slightly smaller, the price somehow higher. The company calls it ‘value engineering.’ Most of us call it what it is: less for more, dressed up in the same wrapper.

The point here is not to mock the food industry or the people who rely on it. The point is structural. The fast food model is a masterpiece of industrial optimization — and industrial optimization, applied to a domain that requires individual judgment, produces a specific and predictable kind of failure. It produces a system that looks like care, prices like care, and markets itself as care, while quietly, persistently, and at enormous scale, delivering something substantially less.

American medicine has been doing the same thing for thirty years. And like the fast food industry, it has perfected the art of making the shrinkage invisible.

The Franchise Model of Health

McDonald’s succeeded not because its food was exceptional, but because it was identical. A Big Mac in Boise is a Big Mac in Baltimore. The operational genius — and the existential trap — of the franchise model is that variation is the enemy of profit. Variation requires judgment. Judgment requires training. Training costs money and introduces liability. So you eliminate it. You standardize. You build the system around the lowest-skill worker who can execute the protocol reliably.

Look across American healthcare and ask yourself: is this not precisely what has happened?

The physician has become a protocol executor. The electronic health record is the POS terminal. The clinical guideline is the laminated prep sheet above the fryer. Treatment decisions that once required individualized clinical reasoning have been compressed into decision trees, checkbox screens, and prior-authorization-approved pathways. The doctor’s role, in the managed care era, is to confirm that the patient fits the protocol — not to ask whether the protocol fits the patient.

This is not an accident. It is a design. And like the design of a franchise kitchen, it optimizes for throughput, not for quality.

Meet Maria: A Patient the System Was Designed For (But Not Designed to Help)

Before examining the economics, consider a patient.

Maria is 58. She presents to her primary care physician with mildly elevated blood pressure — 142/88 on two readings — and mild bilateral ankle swelling she attributes to long days on her feet. She is started on amlodipine, a calcium channel blocker, which is guideline-concordant. Twelve weeks later, the ankle swelling has worsened. Her physician, seeing edema in the chart without recalling the new medication — she sees a different provider in the same practice today — adds hydrochlorothiazide for presumptive volume overload. Over the next four months, Maria develops urinary urgency and two episodes of incontinence. She is referred to urology, where she is started on an anticholinergic. By her next annual visit, her family has noticed she seems more forgetful. She is referred to neurology for cognitive evaluation.

Maria now has four specialists, five medications, and a preliminary diagnosis of early cognitive impairment. What she has, in reality, is a well-documented side effect of amlodipine — edema — that cascaded through a system with no mechanism for stepping back and asking the original question: does this patient even need a pharmaceutical? Her hypertension was borderline. Her diet was high in sodium and low in potassium and magnesium. She had not been counseled on any of this, because counseling is not billable at the reimbursement rate of a prescription, and the visit time did not permit it.

Maria is not unusual. Maria is the system working as designed.

Read the rest here.